Scientific Advisory Board and External Review Panel
Scientists in the fields of oncology, glycobiology and epidemiology as well as clinicians in the cancer field are appointed as expert advisors to Against Breast Cancer who, alongside our Research Advocates, comprise our Scientific Advisory Board.
Research Advocates are non-scientists who help us ensure that we fund research that is relevant to patients and the public and help us clearly communicate our Research Strategy. Other scientific experts also form an External Review Panel to provide additional written review of large grant applications. Hereon in, these groups of people are collectively referred to as ‘Advisors’.
Against Breast Cancer make every effort to ensure that our Advisors are balanced appropriately in terms of gender, age and ethnicity, as well as expertise and experience in line with our Research Strategy.
Where do we find Independent Advisors?
Scientific experts are identified using a broad range of sources such as literature search (Entrez Pubmed), online networking (researchgate.net, LinkedIn), recommendations from SAB members and networking at conferences (e.g. National Cancer Research Institute).
Research Advocates are sourced from our base of both corporate and public supporters and in line with recommended practice by the National Institute of Health Research (NIHR) Research Design Service. For more information see ‘Public and Patient Involvement’.
All Advisors are independent of the charity. Current Trustees and those employed by Against Breast Cancer are not permitted to be Advisors.
All appointments to the Scientific Advisory Board must be approved by the Trustee Board, therefore expert scientists and Research Advocates that are identified as possible members must be declared to the Trustees before an invitation to the Scientific Advisory Board is extended.
Members of the External Review Panel do not need to be approved; the Trustees will be kept informed as to new appointments to this larger Panel of scientists.
Advisors must declare any competing interests in line with our Conflicts of Interest Policy to enable a fair and impartial review of funding applications.
All Advisors sign a Terms of Reference that clearly lays out their roles and responsibilities and confidentiality requirements.